UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025086 |
|---|---|
| Receipt number | R000028849 |
| Scientific Title | Predictive and progonstic biomarkers of nivolumab and pembrolizumab treatment in Renal cell and urothelial carcinoma |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2020/06/03 10:07:10 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/11/30 18:11:13 | ||
| 2 | Update | 2018/05/18 19:59:07 | Recruitment status |
|
| 3 | Update | 2018/05/18 20:00:11 | Public title Public title |
|
| 4 | Update | 2018/05/18 20:02:28 | Condition Condition Narrative objectives1 Narrative objectives1 Primary outcomes |
|
| 5 | Update | 2018/05/18 20:04:17 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Target sample size |
|
| 6 | Update | 2018/05/18 20:05:08 | Other related information |
|
| 7 | Update | 2020/06/03 09:59:57 | Public title Scientific Title |
|
| 8 | Update | 2020/06/03 10:03:05 | Condition Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 9 | Update | 2020/06/03 10:04:31 | Key inclusion criteria Key exclusion criteria Target sample size |
|
| 10 | Update | 2020/06/03 10:07:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
